Rationale for a phase III study of erythropoietin as a neurocognitive protectant in patients with lung cancer receiving prophylactic cranial irradiation
- 1 December 2002
- journal article
- review article
- Published by Elsevier in Seminars in Oncology
- Vol. 29 (6 Suppl 19), 47-52
- https://doi.org/10.1053/sonc.2002.37362